Home / Compliance actions / 610364

FDA Warning Letter — DongBang Cosmetics Co., Ltd.

Case 610364 — FEI 3013677509

The FDA took a Warning Letter action against DongBang Cosmetics Co., Ltd. on Oct 22, 2021 (Seo District, South Korea). The action was issued by CDER and concerns drugs products.

Action Details

Facility
DongBang Cosmetics Co., Ltd.
Date
Oct 22, 2021
Fiscal Year
2022
Product Type
Drugs
Center
CDER
Location
Seo District (South Korea)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.